SYDNEY: A class action over birth defects linked to the morning sickness drug thalidomide was settled in an Australian court, with the British distributor agreeing to pay victims AU$89mil (RM256mil).
Lawyers representing some 100 Australian and New Zealand victims of the drug told the Victorian Supreme Court that settlement had been reached with Diageo, which owns now-defunct thalidomide distributor The Distillers Company.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
